Using miR-22 overexpression, Gal-1 siRNA, and a small molecule to inhibit Gal-1, the presented data revealed the vital roles of the miR-22-Gal-1 axis in HCC development and treatment. The gene discussed is LGALS1; the disease is hepatocellular carcinoma.